- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on High-Risk and Oligometastatic Prostate Cancer in Ireland
Total 176 results
-
Cancer Trials IrelandJanssen, LPCompleted
-
Cancer Trials IrelandCompletedProstate Cancer | Metastatic CancerIreland
-
Cancer Trials IrelandUnknown
-
Cancer Trials IrelandActive, not recruiting
-
Kira MurphyIrish Research Council; University of Pittsburgh Medical Center; Waterford Instituate...RecruitingExercise | Prostate CancerIreland
-
St. Luke's Hospital, IrelandUnknownProstate CancerIreland, United Kingdom
-
Cancer Trials IrelandCompleted
-
Guy's and St Thomas' NHS Foundation TrustQueen's University, Belfast; University of Bristol; University of Glasgow; University... and other collaboratorsRecruitingProstate CancerUnited Kingdom
-
Cancer Trials IrelandUniversity College Dublin; Technological University DublinRecruitingNSCLC/Oligometastatic Cancer (Single Lung Lesion)Ireland
-
Irish Centre for Fetal and Neonatal Translational...University College Cork; National Maternity Hospital, Ireland; Coombe Women and... and other collaboratorsCompletedPregnancy Complications | Pregnancy, High Risk | Pre-eclampsiaIreland
-
Brown UniversityAstraZeneca; The Miriam Hospital; Rhode Island HospitalTerminatedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Cancer Trials IrelandCompleted
-
SanofiCompletedProstate Cancer MetastaticUnited Kingdom, Austria, Belgium, Czechia, France, Germany, Greece, Iceland, Ireland, Italy, Netherlands, Norway, Spain
-
Reykjavik UniversityThe Icelandic Research Fund; The Icelandic Cancer SocietyCompleted
-
European Organisation for Research and Treatment...CompletedProstate CancerBelgium, Italy, France, Netherlands, United Kingdom, Poland, Ireland, Spain, Cyprus, Czech Republic, Luxembourg
-
Brown UniversityBayer; The Miriam Hospital; Rhode Island Hospital; Clovis Oncology, Inc.Active, not recruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Roger Williams Medical CenterSuspendedTrial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative ConditioningProstate CancerUnited States
-
University Urological Associates Inc.Unknown
-
Cancer Trials IrelandTerminatedMetastatic Cancer | Bone Metastases | Castration-resistant Prostate CancerIreland
-
Brown UniversityThe Miriam Hospital; Rhode Island HospitalCompletedProstate CancerUnited States
-
Brown UniversityTerminated
-
Galway ClinicUnknownMetabolic Syndrome | Prostate Cancer | Intermittent FastingIreland
-
Scandinavian Prostate Cancer GroupUnknownProstate CancerFinland, Denmark, Iceland, Norway, Sweden
-
Progenics Pharmaceuticals, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Cancer of the Prostate | Prostatic Neoplasm | Progressive mCRPCUnited States, Canada
-
Movember FoundationKing's College London; Centre hospitalier de l'Université de Montréal (CHUM); University of California, San Francisco and other collaboratorsActive, not recruitingINTense ExeRcise for surviVAL Among Men With Metastatic Prostate Cancer (INTERVAL - GAP4) (INTERVAL)Metastatic Prostate CancerUnited States, Australia, Netherlands, Canada, United Kingdom, Germany, Ireland
-
UNICANCERBayerRecruitingProstate Cancer MetastaticSpain, France, Ireland, Belgium
-
Brown UniversityKeitner/Family Therapy Research GrantCompletedBreast Cancer | Sexual Dysfunction | Prostate CancerUnited States
-
Roger Williams Medical CenterSuspendedTrial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative ConditioningMonitor Adverse EventsUnited States
-
Tampere UniversityCompletedProstate CancerFinland, Ireland, Sweden
-
Astellas Pharma Global Development, Inc.PfizerCompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerUnited States
-
BioProtectActive, not recruitingProstate CancerIsrael, Netherlands, Portugal, Ireland, Poland
-
AstraZenecaCompletedNon-Metastatic Prostate CancerCzech Republic, Italy, South Africa, United Kingdom, Germany, Poland, Netherlands, Austria, Belgium, Hungary, Israel, Portugal, Mexico, Spain, Australia, Ireland
-
Christopher Sweeney, MBBSSanofi; Hoosier Cancer Research Network; Walther Cancer InstituteTerminatedMetastatic Prostate CancerUnited States, Canada
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark
-
Sidekick HealthLandspitali University Hospital; Ljósið Cancer Rehabilitation CenterActive, not recruitingCancer | Colorectal Cancer | Lung Cancer | Prostate CancerIceland
-
Louise KennyErasmus Medical Center; University of Liverpool; Copenhagen Trial Unit, Center... and other collaboratorsUnknownPregnancy Complications | Pregnancy | Pre-eclampsia | Pregnancy, High-riskIreland, Netherlands, Sweden, United Kingdom
-
Astellas Pharma IncAstellas Pharma US, Inc.TerminatedProstatic Neoplasms | Hormone-Refractory Prostate CancerUnited States, Ireland, Australia, France, United Kingdom, Belgium, Germany, Netherlands, Poland, Spain
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
Rahul AggarwalNovartisCompletedProstate CancerUnited States
-
SanofiCompletedProstate Cancer MetastaticAustralia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Finland, Hungary, India, Ireland, Italy, Kazakhstan, Luxembourg, Malaysia, Mexico, Philippines, Poland, Portugal, Romania, Serbia, Singapo... and more
-
University of Dublin, Trinity CollegeCompletedObesity | Prostate CancerIreland, United Kingdom
-
AmgenCompletedCarcinoma | Cancer | Prostate Cancer | Tumors | Castrate-Resistant Prostate CancerUnited States, Canada, Poland, Hungary, Finland, Mexico
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Prostate Carcinoma | Stage IIA Prostate Cancer AJCC v7 | Stage III Prostate Cancer AJCC v7 | Stage I Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7United States, Ireland
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate CancerUnited States, Canada
-
DendreonCompletedProstatic Neoplasms | Advanced Prostate CancerUnited States
-
Institute of Cancer Research, United KingdomUnknownProstate CancerUnited Kingdom
-
Ronald HoffmanNational Cancer Institute (NCI); Roche Pharma AG; Myeloproliferative Disorders-Research...CompletedHigh Risk Polycythemia Vera | High Risk Essential ThrombocythemiaUnited States, Italy, United Kingdom, France
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Astellas Pharma US, Inc.; Medivation, Inc.; Biologics...Active, not recruitingRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States, Canada, Puerto Rico